Nuveen Insured Muni Opportunity Fund (NIO) 14.67

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nuveen Insured Muni Opportunity Fund (NIO) 14.67 $NIO

Nuveen Announces Completion of National Municipal Closed-End Fund Mergers
BusinessWire - Mon Apr 11, 8:00AM CDT
Nuveen Investments, a leading global provider of investment services to individual investors and their financial advisors, today announced that the reorganizations of eight national municipal closed-end funds were completed prior to the open of the New York Stock Exchange on April 11, 2016. Additionally, the acquiring funds, Nuveen Dividend Advantage Municipal Fund 3 (NYSE:NZF) and Nuveen Dividend Advantage Municipal Income Fund (NYSE:NVG) have been renamed Nuveen Enhanced Municipal Credit Opportunities Fund and Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund, respectively. The funds will continue to trade under the symbols NZF and NVG.
NPT: 13.70 (-0.08), NXZ: 14.96 (-0.07), NQU: 14.89 (-0.04), NIO: 14.67 (-0.04), NVG: 16.10 (+0.13), NQI: 14.26 (-0.03), NZF: 15.72 (+0.04), NMA: 14.54 (-0.01)

Eight Nuveen National Municipal Closed-End Funds Declare Pre-Merger Distributions
BusinessWire - Tue Mar 29, 4:41PM CDT
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced distributions for eight national municipal closed-end funds. The specific distribution dates and amounts are detailed below. As previously announced, the shareholders of these funds approved the reorganization of the funds into two, larger funds with distinct investment mandates.
NPT: 13.70 (-0.08), NXZ: 14.96 (-0.07), NQU: 14.89 (-0.04), NIO: 14.67 (-0.04), NVG: 16.10 (+0.13), NQI: 14.26 (-0.03), NZF: 15.72 (+0.04), NMA: 14.54 (-0.01)

Nuveen Announces Shareholder Approval of Municipal Closed-End Fund Merger
BusinessWire - Wed Mar 02, 3:49PM CST
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that shareholders of four Nuveen national municipal closed-end funds approved a fund merger. As previously announced, the mergers are intended to create larger funds with lower operating expenses and increased trading volumes on the exchange for common shares.
NPT: 13.70 (-0.08), NXZ: 14.96 (-0.07), NQU: 14.89 (-0.04), NIO: 14.67 (-0.04), NVG: 16.10 (+0.13), NQI: 14.26 (-0.03), NZF: 15.72 (+0.04), NMA: 14.54 (-0.01)

Nuveen Closed-End Funds Declare Distributions
BusinessWire - Mon Jan 04, 4:06PM CST
--Regular Monthly Tax-Exempt and Taxable Fund Distributions
NTC: 13.82 (-0.02), NKG: 14.39 (+0.06), NBD: 22.46 (+0.24), NOM: 16.35 (-0.35), JLS: 22.91 (unch), JQC: 7.94 (-0.19), NXC: 16.87 (+0.23), JPI: 23.47 (-0.14), JTP: 8.41 (+0.04), JHP: 8.79 (+0.04), NBB: 22.40 (+0.13), NKX: 16.87 (+0.07), NSL: 6.00 (-0.09), JHY: 10.49 (+0.04), JPS: 9.40 (+0.01), NAZ: 16.71 (+0.18), JPW: 15.68 (-0.10), NNC: 14.70 (+0.01), NVX: 16.69 (+0.04), JMT: 22.00 (-0.04), JMM: 7.29 (-0.05), NJV: 15.74 (-0.03), NCB: 17.88 (+0.12), NCA: 11.19 (+0.04), NRK: 14.13 (unch), JMF: 12.45 (-0.44), NNY: 10.40 (+0.05), NMI: 12.93 (-0.13), NVG: 16.10 (+0.13), NQI: 14.26 (-0.03), JSD: 15.72 (-0.09), NZF: 15.72 (+0.04), NQM: 16.43 (+0.06), NUW: 18.79 (+0.05), NMA: 14.54 (-0.01), NQP: 15.14 (+0.04), NZH: 15.75 (-0.02), NQS: 15.32 (+0.07), JRI: 16.21 (-0.38), JFR: 10.45 (-0.07), NMY: 13.91 (+0.02), NQU: 14.89 (-0.04), NUO: 16.71 (+0.07), NMZ: 14.90 (+0.15), JRO: 10.34 (-0.20), NUV: 10.72 (+0.09), NMO: 14.91 (+0.06), NYV: 16.20 (-0.02), NMS: 16.63 (-0.09), NMT: 15.62 (+0.07), NUM: 15.19 (+0.06), NEV: 16.20 (+0.02), NXZ: 14.96 (-0.07), NIQ: 13.72 (+0.08), NIO: 14.67 (-0.04), NIM: 10.83 (+0.04), NPI: 15.19 (+0.10), NPF: 14.88 (+0.08), DRA: 16.34 (-0.14), NPM: 15.27 (+0.04), JPC: 10.03 (-0.10), NTX: 15.57 (-0.06), NPP: 16.39 (+0.10), JGH: 14.38 (-0.14), NPN: 16.37 (+0.01), NXJ: 15.19 (+0.10), NPT: 13.70 (-0.08), JMLP: 9.23 (-0.30), NAD: 15.51 (+0.08), NXN: 14.75 (+0.28), NEA: 14.79 (+0.01), NAC: 16.79 (+0.09), NXP: 15.36 (+0.09), NPV: 14.77 (+0.11), NXQ: 14.72 (+0.03), NXR: 15.52 (+0.05), NAN: 15.54 (+0.03), NID: 14.02 (+0.16)

Several Nuveen Closed-End Funds Declare Capital Gains
BusinessWire - Tue Dec 01, 4:40PM CST
Nuveen Investments, a leading global provider of investment services to institutions, as well as individual investors, today announced that several closed-end funds have declared additional cash distributions with the record, ex-dividend and payable date outlined below.
NTC: 13.82 (-0.02), NKG: 14.39 (+0.06), NOM: 16.35 (-0.35), NXC: 16.87 (+0.23), NKX: 16.87 (+0.07), NAZ: 16.71 (+0.18), NVX: 16.69 (+0.04), NNC: 14.70 (+0.01), NJV: 15.74 (-0.03), NCB: 17.88 (+0.12), NCA: 11.19 (+0.04), NRK: 14.13 (unch), NNY: 10.40 (+0.05), NMI: 12.93 (-0.13), NVG: 16.10 (+0.13), NQI: 14.26 (-0.03), NZF: 15.72 (+0.04), NQM: 16.43 (+0.06), NUW: 18.79 (+0.05), NMA: 14.54 (-0.01), NQP: 15.14 (+0.04), NZH: 15.75 (-0.02), NQS: 15.32 (+0.07), NMY: 13.91 (+0.02), NQU: 14.89 (-0.04), NMZ: 14.90 (+0.15), NUO: 16.71 (+0.07), NUV: 10.72 (+0.09), NMO: 14.91 (+0.06), NYV: 16.20 (-0.02), NMS: 16.63 (-0.09), NMT: 15.62 (+0.07), NUM: 15.19 (+0.06), NIQ: 13.72 (+0.08), NXZ: 14.96 (-0.07), NEV: 16.20 (+0.02), NIO: 14.67 (-0.04), NIM: 10.83 (+0.04), NPI: 15.19 (+0.10), NPF: 14.88 (+0.08), NPM: 15.27 (+0.04), NTX: 15.57 (-0.06), NPP: 16.39 (+0.10), NPN: 16.37 (+0.01), NXJ: 15.19 (+0.10), NPT: 13.70 (-0.08), NXN: 14.75 (+0.28), NAD: 15.51 (+0.08), NEA: 14.79 (+0.01), NAC: 16.79 (+0.09), NXP: 15.36 (+0.09), NPV: 14.77 (+0.11), NXQ: 14.72 (+0.03), NXR: 15.52 (+0.05), NAN: 15.54 (+0.03), NID: 14.02 (+0.16)

Nuveen Closed-End Funds' Proposals Receive Support of Leading Proxy Advisory Service
BusinessWire - Mon Nov 23, 8:00AM CST
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that Institutional Shareholder Services Inc. (ISS) has recommended that shareholders vote in favor of a plan to merge eight national municipal closed-end funds and to reposition the portfolios of the two acquiring funds. ISS is widely recognized as the leading independent proxy advisory firm in the nation. Its recommendations are relied upon by hundreds of major institutional investment firms, mutual funds, and other fiduciaries throughout the country.
NPT: 13.70 (-0.08), NXZ: 14.96 (-0.07), NQU: 14.89 (-0.04), NIO: 14.67 (-0.04), NVG: 16.10 (+0.13), NQI: 14.26 (-0.03), NZF: 15.72 (+0.04), NMA: 14.54 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading